NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
Taiwan Semiconductor
TSM
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
MTNB Matinas BioPharma
- 0.5580
- +0.0080+1.45%
Close Mar 4 16:00 ET
- 0.5580
- 0.00000.00%
Post 20:01 ET
2.84MMarket Cap-0.12P/E (TTM)
0.5599High0.5201Low102.69KVolume0.5500Open0.5500Pre Close55.59KTurnover2.23%Turnover RatioLossP/E (Static)5.09MShares21.500052wk High0.18P/B2.57MFloat Cap0.478052wk Low--Dividend TTM4.60MShs Float197.5000Historical High--Div YieldTTM7.24%Amplitude0.4780Historical Low0.5410Avg Price1Lot Size
About Matinas BioPharma Company
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Company Profile
SymbolMTNB
Company NameMatinas BioPharma
Listing DateMar 2, 2017
Founded2013
CEOMr. Jerome D. Jabbour, J.D.
MarketAMEX
Employees32
Fiscal Year Ends12-31
Address1545 Route 206 South,Suite 302
CityBedminster
ProvinceNew Jersey
CountryUnited States of America
Zip Code07921-9999
Phone1-908-484-8805
Company Executives
- Name
- Position
- Salary
- Jerome D. Jabbour, J.D.
- Chief Executive Officer, President and Director
- --
- Keith A. Kucinski, C.P.A.,M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Eric J. Ende, M.B.A.,M.D.
- Chairman of the Board
- --
- Evelyn D’An
- Independent Director
- --
- Natasha Giordano
- Independent Director
- --
- Dr. Matthew A. Wikler, M.B.A.,M.D.
- Independent Director
- --
- Dr. Robin L. Smith, M.B.A.,M.D.
- Independent Director
- --